CCM
XENE icon

Cinctive Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Cinctive Capital Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,317
Closed -$1.05M – 534
2025
Q4 		$1.05M Buy
23,317
+263
+1% +$11K 0.06% 280
2025
Q3 		$926K Buy
+23,054
New +$812K 0.05% 309
2024
Q3 		– Sell
-20,520
Closed -$800K – 546
2024
Q2 		$800K Sell
20,520
-11,250
-35% -$450K 0.04% 325
2024
Q1 		$1.37M Buy
31,770
+4,170
+15% +$192K 0.07% 255
2023
Q4 		$1.27M Buy
+27,600
New +$975K 0.09% 229
2022
Q3 		– Sell
-41,073
Closed -$1.25M – 672
2022
Q2 		$1.25M Sell
41,073
-1,230
-3% -$37.2K 0.06% 367
2022
Q1 		$1.29M Hold
42,303
– – 0.06% 376
2021
Q4 		$1.32M Buy
+42,303
New +$1.26M 0.06% 363

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return